ALK5-IN-8
Modify Date: 2024-07-17 19:06:54
ALK5-IN-8 structure
|
Common Name | ALK5-IN-8 | ||
|---|---|---|---|---|
| CAS Number | 2705900-81-6 | Molecular Weight | 350.35 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H15FN4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ALK5-IN-8ALK5-IN-8 is a potent inhibitor of TGFβRI (ALK5). ALK5-IN-8 Inhibits the phosphorylation of ALK5 on its downstream signaling proteins (Smad2 or Smad3) by blocking the binding of TGFβRI to ligands, thereby affecting or blocking TGF-β signaling. ALK5-IN-8 has the potential for the research of various ALK5-mediated related diseases (extracted from patent WO2021190425A1, compound 1)[1]. |
| Name | ALK5-IN-8 |
|---|
| Description | ALK5-IN-8 is a potent inhibitor of TGFβRI (ALK5). ALK5-IN-8 Inhibits the phosphorylation of ALK5 on its downstream signaling proteins (Smad2 or Smad3) by blocking the binding of TGFβRI to ligands, thereby affecting or blocking TGF-β signaling. ALK5-IN-8 has the potential for the research of various ALK5-mediated related diseases (extracted from patent WO2021190425A1, compound 1)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Zhiyong Yu, et al. Transforming growth factor-beta receptor inhibitor. Patent WO2021190425A1. |
| Molecular Formula | C19H15FN4O2 |
|---|---|
| Molecular Weight | 350.35 |